Similar findings were reported in a recent multicentric study by Aoun M. and colleagues, in which the group of AKI human patients treated with EPO did not show a better outcome or a lower need for blood transfusion compared to the control group [15]. This evidence concerns the gene EPO and acute kidney injury.